Completed OBSERVATIONAL NCT05151536

Effects of Different Doses of Epinephrine on Biomarkers of Nervous System Ischemia-reperfusion Injury in Patients With Stanford Type A Dissection

To Explore the Impact of Epinephrine on Biomarkers of Nervous System Ischemia-reperfusion Injury in Patients With Stanford Type A Dissection

Sponsor: Yunlong Fan

Conditions Adrenaline; Aortic Dissection; Drug Dose; Nervous System; Ischemia Reperfusion Injury

Updated 3 times since 2022 Last updated: Dec 8, 2021 Started: Jan 1, 2012 Primary completion: Jan 1, 2019 Completion: Jan 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05151536, this observational or N/A phase trial focuses on Adrenaline; Aortic Dissection; Drug Dose; Nervous System; Ischemia Reperfusion Injury and remains completed. Sponsored by Yunlong Fan, it has been updated 3 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2022 — Jul 2024 [monthly]

Completed

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yunlong Fan

Data source: Chinese PLA General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.